Larvol Delta - 1ST-Biotherapeutics-Announces-Clinical-Trial-Collaboration-and-Supply-Agreement-with-MSD-to-Evaluate-FB849-in-Combination-With-KEYTRUDA-pembrolizumab

FB849 - 1ST Bio

Keytruda (pembrolizumab) - Merck (MSD)

https://www.globenewswire.com/news-release/2023/09/19/2745343/0/en/1ST-Biotherapeutics-Announces-Clinical-Trial-Collaboration-and-Supply-Agreement-with-MSD-to-Evaluate-FB849-in-Combination-With-KEYTRUDA-pembrolizumab.html

Sep 19, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next